Magnesiumsulfat nedsætter risikoen for cerebral parese efter præterm fødsel
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Children born preterm have an increased risk of severe morbidity, e.g. cerebral palsy (CP), compared to children born at term. CP cannot be treated, which is why a prophylactic approach is essential, as argued in this review. Six randomised controlled trials (RCTs) have provided data on MgSO4 treatment as CP neuroprotection in preterm birth, including a new RCT from Denmark. Recently, an updated meta-analysis with trial sequential analysis detected a significant neuroprotective effect of MgSO4 treatment in preterm birth. There is now sufficient evidence, that MgSO4 treatment should be used as neuroprotection in preterm birth.
Bidragets oversatte titel | Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth |
---|---|
Originalsprog | Dansk |
Artikelnummer | V06200441 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 182 |
Udgave nummer | 47 |
Antal sider | 8 |
ISSN | 0041-5782 |
Status | Udgivet - 2020 |
Links
- https://ugeskriftet.dk/files/scientific_article_files/2020-11/v06200441_web.pdf
Forlagets udgivne version
ID: 269795800